T2D B-Cell Differentiation and Isotype Switching
Gu et al. report that B-cell states in T2D PBMCs shift away from naive B cells and toward intermediate B cells, plasma cells, and more diverse BCR isotypes.
Key Findings
- B-cell reclustering identified naive B cells, memory B cells, plasma cells, and intermediate B-cell states marked by TNFR2 or NFKB-related expression.
- Naive B-cell proportions were lower in T2D than non-diabetes controls.
- Intermediate B_TNFR2+, intermediate B_NFKB+, and plasma-cell proportions were higher in T2D.
- BCR analysis showed higher plasma-cell differentiation and increased BCR isotype diversity in T2D participants.
- The paper reports increased secretion-related IgA and IgG antibody signals in T2D.
Interpretation
- The B-cell findings are consistent with an activated adaptive immune environment in T2D.
- The authors note that TNFR2+ intermediate B cells may have a counteractive anti-inflammatory role through IL-10, so their increase should not be interpreted as purely pro-inflammatory without functional validation.
- Increased B-cell differentiation may be downstream of CD4 T-cell help, but the Gu et al. study does not directly establish causality.
Manuscript Use
- This page supports adaptive immune remodeling claims for PBMC immune changes in type 2 diabetes.
- It is most useful when paired with monocyte and T-cell pages to describe a possible monocyte-T-cell-B-cell inflammatory network.
Links
- gu-2024-single-cell-pbmcs-t2d
- t2d-cytotoxic-t-cell-expansion
- single-cell-pbmc-profiling-in-type-2-diabetes